Credit Suisse’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4263 |
|
|
2022
Q2 | – | Sell |
-2,022
| Closed | -$198K | – | 4287 |
|
|
2022
Q1 | $198K | Buy |
2,022
+72
| +4% | +$7.05K | ﹤0.01% | 3358 |
|
|
2021
Q4 | $319K | Buy |
1,950
+1,032
| +112% | +$169K | ﹤0.01% | 3277 |
|
|
2021
Q3 | $250K | Buy |
918
+48
| +6% | +$13.1K | ﹤0.01% | 3309 |
|
|
2021
Q2 | $345K | Sell |
870
-193
| -18% | -$76.5K | ﹤0.01% | 3214 |
|
|
2021
Q1 | $574K | Sell |
1,063
-1,032
| -49% | -$557K | ﹤0.01% | 2877 |
|
|
2020
Q4 | $791K | Sell |
2,095
-79
| -4% | -$29.8K | ﹤0.01% | 2716 |
|
|
2020
Q3 | $822K | Buy |
2,174
+119
| +6% | +$45K | ﹤0.01% | 2394 |
|
|
2020
Q2 | $1.01M | Buy |
2,055
+541
| +36% | +$266K | ﹤0.01% | 2317 |
|
|
2020
Q1 | $556K | Buy |
1,514
+160
| +12% | +$58.8K | ﹤0.01% | 2465 |
|
|
2019
Q4 | $957K | Buy |
1,354
+3
| +0.2% | +$2.12K | ﹤0.01% | 2545 |
|
|
2019
Q3 | $867K | Buy |
1,351
+675
| +100% | +$433K | ﹤0.01% | 2489 |
|
|
2019
Q2 | $591K | Buy |
676
+75
| +12% | +$65.6K | ﹤0.01% | 2684 |
|
|
2019
Q1 | $346K | Buy |
601
+15
| +3% | +$8.64K | ﹤0.01% | 2961 |
|
|
2018
Q4 | $164K | Buy |
586
+92
| +19% | +$25.7K | ﹤0.01% | 3171 |
|
|
2018
Q3 | $237K | Sell |
494
-251
| -34% | -$120K | ﹤0.01% | 3135 |
|
|
2018
Q2 | $338K | Sell |
745
-152
| -17% | -$69K | ﹤0.01% | 3128 |
|
|
2018
Q1 | $527K | Buy |
897
+202
| +29% | +$119K | ﹤0.01% | 2920 |
|
|
2017
Q4 | $432K | Sell |
695
-403
| -37% | -$250K | ﹤0.01% | 3013 |
|
|
2017
Q3 | $1.01M | Buy |
1,098
+289
| +36% | +$266K | ﹤0.01% | 2635 |
|
|
2017
Q2 | $755K | Sell |
809
-409
| -34% | -$382K | ﹤0.01% | 2515 |
|
|
2017
Q1 | $1.16M | Buy |
1,218
+264
| +28% | +$251K | ﹤0.01% | 2416 |
|
|
2016
Q4 | $766K | Buy |
954
+252
| +36% | +$202K | ﹤0.01% | 2879 |
|
|
2016
Q3 | $593K | Sell |
702
-56
| -7% | -$47.3K | ﹤0.01% | 3006 |
|
|
2016
Q2 | $624K | Sell |
758
-574
| -43% | -$473K | ﹤0.01% | 2990 |
|
|
2016
Q1 | $1.48M | Buy |
1,332
+257
| +24% | +$286K | ﹤0.01% | 2172 |
|
|
2015
Q4 | $1.34M | Sell |
1,075
-1,877
| -64% | -$2.34M | ﹤0.01% | 2388 |
|
|
2015
Q3 | $3.99M | Buy |
2,952
+1,491
| +102% | +$2.02M | ﹤0.01% | 1610 |
|
|
2015
Q2 | $2.63M | Buy |
1,461
+1,001
| +218% | +$1.8M | ﹤0.01% | 2110 |
|
|
2015
Q1 | $743K | Buy |
460
+231
| +101% | +$373K | ﹤0.01% | 2975 |
|
|
2014
Q4 | $175K | Sell |
229
-256
| -53% | -$196K | ﹤0.01% | 3938 |
|
|
2014
Q3 | $191K | Sell |
485
-105
| -18% | -$41.4K | ﹤0.01% | 3752 |
|
|
2014
Q2 | $358K | Sell |
590
-219
| -27% | -$133K | ﹤0.01% | 3590 |
|
|
2014
Q1 | $555K | Buy |
809
+260
| +47% | +$178K | ﹤0.01% | 3271 |
|
|
2013
Q4 | $358K | Buy |
549
+327
| +147% | +$213K | ﹤0.01% | 3530 |
|
|
2013
Q3 | $131K | Sell |
222
-100
| -31% | -$59K | ﹤0.01% | 3635 |
|
|
2013
Q2 | $102K | Buy |
+322
| New | +$102K | ﹤0.01% | 3610 |
|